Vol 27, No 6 (2020)
Study Protocol
Published online: 2020-10-26

open access

Page views 833
Article views/downloads 828
Get Citation

Connect on Social Media

Connect on Social Media

Pomeranian atRial flOw reguLatOr iN conGestive hEart failuRe (PROLONGER): Study protocol

Łukasz Lewicki12, Katarzyna Kosmalska3, Sebastian Liedtke2, Maciej Karwowski2, Janusz Siebert1, Robert Sabiniewicz4, Jakub Kiedrzyn2, Adrian Kot2, Marek Szołkiewicz2
Pubmed: 33140394
Cardiol J 2020;27(6):879-883.


Not available

Article available in PDF format

View PDF Download PDF file


  1. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007; 93(9): 1137–1146.
  2. Redfield MM, Jacobsen SJ, Burnett JC, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003; 289(2): 194–202.
  3. Ponikowski P, Voors A, Anker S, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016; 37(27): 2129–2200.
  4. Lam CSP, Voors AA, de Boer RA, et al. Heart failure with preserved ejection fraction: from mechanisms to therapies. Eur Heart J. 2018; 39(30): 2780–2792.
  5. Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J. 2011; 32(6): 670–679.
  6. Shah SJ, Feldman T, Ricciardi MJ, et al. One-Year safety and clinical outcomes of a transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction in the reduce elevated left atrial pressure in patients with heart failure (REDUCE LAP-HF I) trial: a randomized clinical trial. JAMA Cardiol. 2018; 3(10): 968–977.
  7. Guimarães L, Bergeron S, Bernier M, et al. Interatrial shunt with the second-generation V-Wave system for patients with advanced chronic heart failure. EuroIntervention. 2020; 15(16): 1426–1428.
  8. Paitazoglou C, Özdemir R, Pfister R, et al. The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction. EuroIntervention. 2019; 15(5): 403–410.
  9. Niu X, Zhang Q, Xiao D, et al. A retrospective study of hemodynamic changes in patients after off-pump coronary artery bypass graft surgery using impedance cardiography. Med Sci Monit. 2019; 25: 3454–3462.
  10. Louvaris Z, Spetsioti S, Andrianopoulos V, et al. Cardiac output measurement during exercise in COPD: A comparison of dye dilution and impedance cardiography. Clin Respir J. 2019; 13(4): 222–231.
  11. Małek ŁA, Mróz A, Czajkowska A, et al. Accuracy of impedance cardiography for hemodynamic assessment during rest and exercise in wheelchair rugby players. Res Q Exerc Sport. 2019; 90(3): 336–343.
  12. Kurpaska M, Krzesiński P, Gielerak G, et al. Exercise impedance cardiography reveals impaired hemodynamic responses to exercise in hypertensives with dyspnea. Hypertens Res. 2019; 42(2): 211–222.
  13. Woltjer HH, Bogaard HJ, de Vries P. The technique of impedance cardiography. Eur Heart J. 1997; 18(9): 1396–1403.
  14. Silver MA, Cianci P, Brennan S, et al. Evaluation of impedance cardiography as an alternative to pulmonary artery catheterization in critically ill patients. Congest Heart Fail. 2004; 10(2 Suppl 2): 17–21.
  15. Lewicki L, Fijalkowska M, Karwowski M, et al. The non-invasive evaluation of heart function in patients with an acute myocardial infarction: The role of impedance cardiography. Cardiol J. 2019 [Epub ahead of print].
  16. Lewicki Ł, Sabiniewicz R, Siebert J, et al. Atrial flow regulator as a novel therapy for patients with chronic heart failure. Cardiol J. 2020; 27(3): 309–311.